[Cuproptosis-related immune gene signature predicts clinical benefits from anti-PD-1/PD-L1 therapy in non-small-cell lung cancer
Linfeng Luo, Anlin Li, Sha Fu, Wei Du, Lina He, Xuanye Zhang, Yixing Wang, Yixin Zhou, Yang Yunpeng, Zhang Li, Shaodong Hong
Topics & Concepts
Lung cancerGene signatureImmunotherapyOncologyProportional hazards modelImmune systemMedicineTumor microenvironmentCancerInternal medicineImmune checkpointSurvival analysisImmunologyGeneBiologyGene expressionBiochemistryCancer Immunotherapy and BiomarkersFerroptosis and cancer prognosisCancer-related molecular mechanisms research